• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,909.65
    642.25 (+1.18%)
  • Jio Platforms
    1,438.95 1,490.00(%)
  • NSE
    1,775.20 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,403.50(%)
  • Anand Rathi Wea.
    2,246.45 1,354.00(%)
  • Ather Energy
    1,782.05 1,741.90(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Laurus Labs
    2,392.00 2,245.00(%)
  • Sagility
    41.79 35.82(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Indian Hotels Co
    824.00 816.00(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • ICICI AMC
    2,688.00 2,528.90(%)
  • Hexaware Tech.
    497.95 400.35(%)
  • Suzlon Energy
    33.21 36.30(%)
  • Godrej Consumer
    777.65 810.35(%)
  • Diamond Power
    350.00 406.80(%)
  • Equitas Sma. Fin
    47.26 51.30(%)
  • APL Apollo Tubes
    2,161.00 1,691.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Terce Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3500.0
  • ISIN : INE499G01013
42.95 1 (2.80%)
  • As on 30 Oct 2026 (EOD)

  • Today’s Low

    40.01

  • Today’s High

    44.00

  • Open

    42.00

  • Perv Close

    41.78

  • 52W Low

    29.00

  • 52W High

    50.00

Key Indicators

  • P/E(TTM)

    15.02

  • Mar.Cap (₹Cr.)

    33.46

  • Div & Yield %

    0.00

  • Book Value(₹)

    12.49

  • Debt-Equity Ratio

    2.80

  • AGM Date

    29-Oct-2026

  • EPS

    2.86

  • P/E Ratio

    15.02

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    33.46

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.79

  • BV (₹)

    12.50

  • Sales( ₹ in Cr.)

    47.47

  • NP (in Cr.)

    2.46

  • NP Var(%)

    347.0

  • Div%

    0.0

  • CPS (₹)

    3.70

  • EPS (₹)

    3.20

  • Traded Value (₹ in Lakhs)

    33.46

  • 52 Week High

    50.00

  • 52 Week Low

    29.00

  • Price BSE

    43.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    33.46

  • P/C Ratio

    11.60

  • P/E Ratio

    13.60

  • Price Vs.BV

    3.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 47.47 50.20 47.97 46.78 40.13 25.18
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 47.47 50.20 47.97 46.78 40.13 25.18
Other Income 0.34 0.31 0.32 0.35 0.31 0.80
Stock Adjustments 0.42 0.38 -1.04 -1.65 2.63 0.26
Total Income 48.23 50.89 47.25 45.48 43.07 26.24
EXPENDITURE :            
Raw Materials 17.56 19.35 16.65 17.70 17.88 10.25
Power and Fuel Cost 0.13 0.15 0.17 0.11 0.16 0.10
Employee Cost 14.89 15.37 15.11 14.38 15.49 12.63
Other Manufacturing Expenses 0.69 0.55 0.22 0.44 1.58 0.93
Selling and Administration Expenses 10.79 11.21 13.44 14.57 5.97 3.93
Miscellaneous Expenses 0.55 0.06 0.07 0.10 0.56 0.37
Employee Benefit Expenses 14.89 15.37 15.11 14.38 15.49 12.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 44.60 46.69 45.67 47.29 41.65 28.20
Operating Profit 3.64 4.20 1.59 -1.81 1.42 -1.97
Interest 0.18 0.42 0.68 0.72 0.40 0.39
Gross Profit 3.46 3.78 0.91 -2.53 1.02 -2.36
Depreciation 0.42 0.38 0.37 0.36 0.28 0.18
Profit Before Tax 3.04 3.40 0.54 -2.89 0.74 -2.54
Current Tax 1.09 0.16 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.26 4.21 0.30 -1.22 -0.13 -0.01
Reported Net Profit 2.20 -0.98 0.24 -1.67 0.87 -2.52
Extraordinary Items -0.25 0.01 0.00 0.00 0.00 -0.18
Adjusted Net Profit 2.45 -0.99 0.24 -1.67 0.87 -2.34
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.93
P & L Balance brought forward -3.21 -2.23 -2.48 -0.80 -1.68 1.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -1.01 -3.21 -2.23 -2.48 -0.80 -1.68
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.83 -1.32 0.33 -2.25 1.18 -3.40
Earnings Per Share(Adj)-Unit Curr 2.83 -1.32 0.33 -2.25 1.18 -3.40
Book Value 12.49 8.26 9.58 9.25 11.50 10.33
Book Value(Adj)-Unit Curr 12.49 8.26 9.58 9.25 11.50 10.33

Shareholding Pattern

  • Promoter Group

    40.03%

  • Public Share Holding

    59.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,075,900 13.81 1,075,900 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 7,500 0.10 7,500 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,035,284 26.12 2,035,284 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,118,684 40.03 3,118,684 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 139,318 1.79 137,718 28
Clearing Members 1,834 0.02 1,834 2
Directors of their Relatives 300 0.00 300 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 143,059 1.84 143,059 28
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 162,623 2.09 162,623 95
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,168,855 15.00 1,168,555 29
Individuals holding nominal share capital up to Rs. 1 lakh 3,056,527 39.23 1,897,777 13,447
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,672,616 59.97 3,511,966 13,631
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,791,300 100.00 6,630,650 13,637

Company Background

Gujarat Terce Laboratories LtdPharmaceuticals - Indian - Formulations

  • Gujarat Terce Laboratories Ltd
  • BSE Code : 3500.0
  • ISIN : INE499G01013

  • Incorporation Year

    1985

  • Registered Office

    122/2 Ravi Estate
    Bileshwarpura Chhatral, Gandhinagar,
    Gujarat-382729

  • Telephone

    91-079-6663 3706

  • FAX

  • Chairman

    Natwarbhai P Prajapati

  • Managing Director

    Aalap Prajapati

  • Company Secretary

    Ashka Solanki

  • Auditor

    Shah Doshi Patel & Associates LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Gujarat Terce Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Terce Labs. 42.95 47.81 47.47 16.03 27.03
Abbott India 26,107.90 7,217.19 6,929.05 34.36 43.78
Astrazeneca Phar 6,298.05 2,304.07 2,275.58 92.82 27.86
Glaxosmi. Pharma 2,515.65 3,932.76 3,790.20 40.19 58.17
Novartis India 1,813.30 393.10 354.33 45.79 15.94
Cipla 1,357.00 20,102.60 18,979.95 41.36 13.88
Bliss GVS Pharma 682.50 773.53 729.81 63.43 12.51
Amrutanjan Healt 493.40 520.13 502.55 26.43 24.16
Fermenta Biotec. 439.75 474.15 450.25 20.53 18.77
Guj. Themis Bio. 374.85 168.25 165.82 100.23 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77